Merck Sharp & Dohme LLC Sustainability Profile
Merck Sharp & Dohme LLC, commonly known as MSD, is a leading global healthcare company headquartered in the United States. Founded in 1891, MSD has established a strong presence in various operational regions, including Europe, Asia, and Latin America, focusing on innovative pharmaceuticals, vaccines, and animal health products. With a commitment to research and development, MSD is renowned for its core offerings, which include groundbreaking treatments in oncology, infectious diseases, and vaccines. The company has achieved significant milestones, such as the development of key therapies that have transformed patient care. Recognised for its robust market position, MSD continues to be a pioneer in the pharmaceutical industry, driven by a mission to improve health outcomes worldwide.
DitchCarbon Score
How does Merck Sharp & Dohme LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merck Sharp & Dohme LLC's score of 73 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Merck Sharp & Dohme LLC's reported carbon emissions
In 2023, Merck Sharp & Dohme LLC reported significant carbon emissions, totalling approximately 7,184,000,000,000 kg CO2e. This figure includes Scope 1 emissions of about 718,400,000,000 kg CO2e, Scope 2 emissions of approximately 184,200,000,000 kg CO2e (market-based) and 356,900,000,000 kg CO2e (location-based), and Scope 3 emissions reaching around 6,184,100,000,000 kg CO2e. The company has set ambitious climate commitments, aiming for carbon neutrality across its operations (Scopes 1 and 2) by 2025. Additionally, Merck Sharp & Dohme LLC targets a 46% reduction in absolute Scope 1 and Scope 2 GHG emissions by 2030, using 2019 as the baseline year. This commitment includes biogenic emissions and removals from bioenergy feedstocks. These targets are cascaded from its parent company, Merck & Co., Inc., which also influences its sustainability initiatives. The company is on track to meet its near-term goals, including a 40% reduction in GHG emissions from 2015 levels by 2025, in accordance with the GHG Protocol for Scope 1 and market-based Scope 2 emissions. Merck Sharp & Dohme LLC's comprehensive approach to reducing its carbon footprint reflects its commitment to sustainability and aligns with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 626.29 | 000,000,000,000,000 | 000,000,000,000,000 |
| Scope 2 | 245.3 | 000,000,000,000,000 | 000,000,000,000,000 |
| Scope 3 | - | 0,000,000,000,000,000 | 0,000,000,000,000,000 |
How Carbon Intensive is Merck Sharp & Dohme LLC's Industry?
How Carbon Intensive is Merck Sharp & Dohme LLC's Location?
Merck Sharp & Dohme LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Merck Sharp & Dohme LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
